Multi-disciplinary Care for Brain Metastases
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: health services intervention.
- Who it may be relevant to
- Registry conditions: Brain Metastases, Adult. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Intensive Multi-Disciplinary Care Initiative for Patients With Newly Diagnosed Brain Metastases
Overview
This is a health services intervention study aimed at understanding the impact of intensive multi-disciplinary care compared with standard care on patient-reported symptom outcomes and prognostic awareness in patients with brain metastases.
Detailed description
This is a cohort study of patient with newly diagnosed brain metastases assigned to standard of care (SOC) or intensive multi-disciplinary care (IMDC). Care for all patients with brain metastases involves complex medical decision making and requires input for multiple stakeholders, including medical oncology, neurosurgery, radiation oncology, and neuro-oncology. Palliative care should be an essential component of the care team for all patients with brain metastases by the very nature of this advanced malignancy. At the University of Vermont, our current process for diagnosis and management of patients with brain metastases relies heavily on the physician and team who make the initial diagnosis to consult others as they see appropriate. This process may look different for different patients. We rationalize that a systematic approach with intensive multidisciplinary care (IMDC) will benefit patients with brain metastases by providing consistent access to multi-disciplinary discussion.
Interventions
- Other health services intervention
Health services intervention
Primary outcome measures
- Patient reported outcomes [Time frame: 6-12 months]
Secondary outcome measures (3)
- Feasibility [Time frame: 6-12 months]
- Patient understanding of prognosis [Time frame: 6-12 months]
- survival [Time frame: 6-12 months]
Eligibility criteria
Inclusion criteria
- Patients of all genders must be at least 18 years of age.
- Patients must have histologically confirmed, newly diagnosed brain metastases from known or suspected solid tumor primary neoplasms.
- Patients must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
- Patients must be able to complete questionnaires in English.
- Patients must have the ability to provide informed consent.
Exclusion criteria
- Patients who are < 18 years of age are not eligible.
- Patients who are Pregnant are not eligible.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- University of Vermont Medical Center — Burlington
Identifiers
NCT: NCT06280300 · UVMMC2203